Literature DB >> 31895087

Treatment Outcome of Modified Argon Laser Photoablation for Conjunctival Cysts.

Jisang Han1, Shin-Hyo Lee2, Chul Young Choi1, Hyun Jin Shin3.   

Abstract

PURPOSE: To evaluate the effectiveness of conjunctival cyst removal using a modified method of argon laser photoablation.
METHODS: Seventeen cases of symptomatic conjunctival cysts were included. After staining the surface of a conjunctival cyst with a dark purple marker, the cyst was incised using a 26-gauge needle. Low-energy argon laser photoablation was then applied around the incision site for a mean of 100 times.
RESULTS: During a mean follow-up period of 13.3 months (range 6-28 months), all conjunctival cysts were successfully corrected by applying either one or 2 laser sessions. Complete resolution occurred after a single laser session in 14 eyes (82.4%). There were 3 cases of recurrence with medium to large cysts, and repeating the same procedure produced surgical success in all of these cases; the conjunctival cyst recurred again after the second laser session in one of the 3 eyes, but this spontaneously regressed without further treatment. No postoperative complications such as conjunctival scarring or persistent ocular irritation were observed.
CONCLUSIONS: Our modified method of argon laser photoablation uses staining of the conjunctival cyst surface to increase the amount of thermal laser energy absorbed by the target. This novel technique is simple and effective for treating conjunctival cysts in an outpatient clinic.

Entities:  

Year:  2020        PMID: 31895087     DOI: 10.1097/ICO.0000000000002245

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

1.  A Novel Approach to Treatment of Conjunctival Cyst Ablation Using Atmospheric Low-Temperature Plasma.

Authors:  Farhad Nejat; Khosrow Jadidi; Shiva Pirhadi; Seyede-Yasamin Adnani; Nazanin-Sadat Nabavi; Mohammad Amin Nejat
Journal:  Clin Ophthalmol       Date:  2020-08-26

2.  Modified argon laser therapy for benign tumor of the eyelid.

Authors:  Jisang Han; Shin-Hyo Lee; Chul Young Choi; Ramin Khoramnia; Jaemin Kim; Hyun Jin Shin
Journal:  BMC Ophthalmol       Date:  2022-09-24       Impact factor: 2.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.